Detection of non inhibitory binding antibodies to von Willebrand factor affecting the clearance of VWF:Ag in von Willebrand disease

被引：0

作者：

Suiter, T. M. ^{[1
]}

Mannucci, P. M. ^{[2
]}

Kempton, C. ^{[3
,4
]}

Laffan, M. ^{[5
]}

Romond, E. H. ^{[6
]}

Shapiro, A. ^{[7
]}

Birschmann, I. ^{[8
]}

Ragni, M. V. ^{[9
,10
]}

Gill, J. C. ^{[11
]}

Yee, T. T. ^{[12
,13
]}

Klamroth, R. ^{[14
]}

Horling, F. M. ^{[15
]}

Reipert, B. M. ^{[15
]}

Turecek, P. L. ^{[1
]}

Varadi, K. ^{[1
]}

Chapman, M. ^{[1
]}

Engl, W. ^{[1
]}

Wong, W. Y.

Ewenstein, B. M.

机构：

[1] Baxter Innovat GmbH, Vienna, Austria

[2] Univ Milan, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy

[3] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA

[4] Emory Univ, Sch Med, Dept Hematol Oncol, Atlanta, GA USA

[5] Hammersmith Hosp, Imperial Coll Sch Med, Dept Hematol, London, England

[6] Univ Kentucky, Hemophilia Treatment Ctr, Lexington, KY 40506 USA

[7] Indiana Hemophilia & Thrombosis Ctr, Indiana, PA USA

[8] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-3000 Hannover, Germany

[9] Univ Pittsburgh, Pittsburg, KS USA

[10] Hemophilia Ctr Western Penn, Dept Med, Div Hematol Oncol, Pittsburg, KS USA

[11] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[12] Royal Free Hosp, Haemophilia Ctr, London NW3 2QG, England

[13] Royal Free Hosp, Thrombosis Unit, London NW3 2QG, England

[14] Vivantes Klinikum Friedrichshain, Klin Innere Med Angiol & Haemostaseol, Berlin, Germany

[15] Baxter BioSci, Immunol, Vienna, Austria

来源：

HAEMOPHILIA | 2012年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：42 / 43

页数：2

共 50 条

[31] Acquired von Willebrand disease: potential contribution of the von Willebrand factor collagen-binding to the identification of functionally inhibiting auto-antibodies to von Willebrand factor: a rebuttal
Guerin, V.
Ryman, A.
Velez, F.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (06) : 1051 - 1052
[32] The challenging management of a child with type 3 von Willebrand disease and antibodies to von Willebrand factor
Pergantou, H.
Xafaki, P.
Adamtziki, E.
Koletsi, P.
Komitopoulou, A.
Platokouki, H.
HAEMOPHILIA, 2012, 18 (03) : e66 - e67
[33] Von Willebrand Factor and von Willebrand disease: prerequisite for diagnostic
Fressinaud, Edith
HEMATOLOGIE, 2014, 20 : 6 - 13
[34] von Willebrand disease and quantitative variation in von Willebrand factor
Mohlke, KL
Ginsburg, D
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (03): : 252 - 261
[35] Comparison between plasma von Willebrand factor (VWF) and VWF antigen II level in normal individuals and patients with von Willebrand disease
DeRomeuf, C
Mazurier, C
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 640 - 640
[36] Von Willebrand factor's clearance
Denis, Cecile V.
Lenting, Peter J.
HEMATOLOGIE, 2006, 12 (01): : 34 - 43
[37] The Y/C1584 mutation of von Willebrand factor in type 2M von willebrand disease: frequency and clearance of von Willebrand factor
Millar, CM
Riddel, AF
Griffioe, A
Jenkin, PV
Brown, SA
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) : 462 - 463
[38] The role of VWF:Ag II in patients with acquired von Willebrand disease
Krause, M
Caron, C
Stier-Brück, I
Vigh, T
Scharrer, I
34th Hemophilia Symposium, 2005, : 207 - 211
[39] INHIBITION OF WILLEBRAND FACTOR IN VON WILLEBRAND DISEASE
MARAGALL, S
CASTILLO, R
ORDINAS, A
LIENDO, F
RODRIGUEZ, M
THROMBOSIS RESEARCH, 1979, 14 (2-3) : 495 - 500
[40] AN ALLOANTIBODY TO VON-WILLEBRAND-FACTOR SELECTIVELY INHIBITING THE BINDING OF VON-WILLEBRAND-FACTOR TO COLLAGEN IN A PATIENT WITH SEVERE VON-WILLEBRAND DISEASE
BUDDE, U
EFFENBERGER, W
OLDENBURG, J
SCHNEPPENHEIM, R
VANGENDEREN, P
DREWKE, E
BRACKMANN, HH
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1161 - 1161

← 1 2 3 4 5 →